Keith W. Pfeil - Jul 1, 2021 Form 4 Insider Report for GLOBUS MEDICAL INC (GMED)

Role
SVP, Chief Financial Officer
Signature
/s/ Kelly G. Huller, Attorney-in-Fact
Stock symbol
GMED
Transactions as of
Jul 1, 2021
Transactions value $
-$20,125
Form type
4
Date filed
7/6/2021, 05:14 PM
Previous filing
Jun 28, 2021
Next filing
Jul 20, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GMED Class A Common Stock Options Exercise $44.4K +833 $53.27 833 Jul 1, 2021 Direct
transaction GMED Class A Common Stock Sale -$64.5K -833 -100% $77.43 0 Jul 1, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GMED Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -833 -3.22% $0.00 25K Jul 1, 2021 Class A Common Stock 833 $53.27 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
F2 These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.